Clinical trial synchronization: Value creation through real-world data

An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While clinical trials are the gold standard for regulatory approval, they do have limitations and pose challenges that real-world data (RWD) could help solve, h...

A path plagued by progression: The chronic kidney disease journey

Subscribe to the blog

Contact us